Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, launched its new NFC-Label for digital authentication of autoinjectors. The new NFC-Label for autoinjectors, in combination with a corresponding smartphone app informs users if the product is still in its originally sealed condition.

The new Autoinjector-Label wraps around the autoinjector, including the cap, and has an integrated NFC chip that can be read with a smartphone app. Before opening the cap for the first time, patients can verify that the product is an original and receive respective confirmation. After opening the cap and label, and subsequently reading the NFC chip once more, patients receive a warning on their smartphones that indicates whether the product was previously opened and/or tampered with, enabling them to check the intactness of their injection aids from anywhere at any time. 

Pharmaceutical manufacturers can integrate additional interactive applications in the label such as product information, demo videos or special apps to support patients during self-medication. Additionally, integrated geo-tracking makes it possible to detect potential gray market activities in local markets. According to the company, the digital Autoinjector-Label for NFC-based tamper evidence can be adapted to existing label designs and does not affect the normal application of the device by the patient.